FindMyKOL
Clinical trialNCT07562399Not, yet, recruitingInterventional

Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda

SponsorDana-Farber Cancer InstituteEnrollment224Breast CancerMedication Adherence
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study aims to evaluate a multi-modal intervention designed to improve adherence to adjuvant endocrine therapy (AET) among patients with ER-positive breast cancer in Rwanda. The intervention includes educational, behavioral, and reminder components, and will be assessed for feasibility and impact on medication adherence.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Rwanda
  • Butaro Cancer Center of Excellence

    Butaro, RN8, Rwanda

    Temidayo Fadelu, MD
United States
  • Boston Children'S Hospital

    Boston, Massachusetts, United States

    Temidayo Fadelu, MD
  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

    Temidayo Fadelu, MD
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Temidayo Fadelu, MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Sept 2026
Primary completion
31 Dec 2027
Completion
31 Dec 2028
Last update posted
20 May 2026
Registered enrollment
224
Registry id
NCT07562399

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.